Literature DB >> 30525299

Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.

Wayne Massuger1, Gregory T C Moore1,2,3, Jane M Andrews4,5, Monique F Kilkenny3,6, Megan Reyneke3, Simon Knowles7, Liz Purcell8, George Alex9, Stephanie Buckton10, Amy T Page11, Nigel Stocks12, Don Cameron9, Francesca Manglaviti1, Paul Pavli13,14.   

Abstract

BACKGROUND: Australia has among the highest prevalence of Crohn disease and ulcerative colitis in the world. Management of the chronic gastrointestinal disorders results in significant societal costs and the standard of care is inconsistent across Australia. AIM: To audit the quality of care received by patients admitted for inflammatory bowel disease (IBD) across Australia against national IBD standards.
METHODS: A retrospective cross-sectional survey and clinical audit was undertaken assessing organisational resources, clinical processes and outcome measures. This study was conducted in Australian hospitals that care for inpatients with Crohn disease or ulcerative colitis. The main outcome measures were adherence to national IBD standards and comparison of quality of care between hospitals with and without multidisciplinary IBD services.
RESULTS: A total of 71 hospitals completed the organisational survey. Only one hospital had a complete multidisciplinary IBD service and 17 had a partial IBD service (IBD nurse, helpline and clinical lead). A total of 1440 inpatient records was reviewed from 52 hospitals (mean age 37 years; 51% female, 53% Crohn disease), approximately 26% of IBD inpatient episodes over a 12-month period in Australia. These patients were chronically unwell with high rates of anaemia (30%) and frequent readmissions (40% within 2 years). In general, care was inconsistent, and documentation was poor. Hospitals with a partial IBD service performed better in many processes and outcome measures: for example, 22% reduction in admissions through emergency departments and greater adherence to standards for safety monitoring of biological (89% vs 59%) and immunosuppressive drugs (79% vs 55%) in those hospitals than those without.
CONCLUSION: Patients admitted to hospital suffering from IBD are young, chronically unwell and are subject to substantial variations in clinical documentation and quality of care. Only one hospital met accepted standards for multidisciplinary care; hospitals with even a minimal IBD service provided improved care.
© 2019 Royal Australasian College of Physicians.

Entities:  

Keywords:  Crohn disease; clinical audit; digestive system disease; gastroenterology; inflammatory bowel disease; ulcerative colitis

Mesh:

Year:  2019        PMID: 30525299     DOI: 10.1111/imj.14187

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  10 in total

Review 1.  Dietary management of adults with IBD - the emerging role of dietary therapy.

Authors:  Jessica A Fitzpatrick; Sarah L Melton; Chu Kion Yao; Peter R Gibson; Emma P Halmos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-16       Impact factor: 73.082

2.  The Influence of the Inflammatory Bowel Diseases on the Perceived Stress and Quality of Life in a Sample of the South-Western Romanian Population.

Authors:  Denisa-Elena Popa; Mihail-Cristian Pîrlog; Dragoş-Ovidiu Alexandru; Dan-Ionuţ Gheonea
Journal:  Curr Health Sci J       Date:  2022-03-31

3.  Management of anaemia in patients with inflammatory bowel disease - results of a questionnaire among Polish healthcare professionals.

Authors:  Edyta M Tulewicz-Marti; Konrad Lewandowski; Martyna Szczubełek; Grażyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2021-03-26

4.  The new frontier: Certifying quality standards in the inflammatory bowel disease care.

Authors:  Gionata Fiorino; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2021-07-10       Impact factor: 6.866

Review 5.  Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products.

Authors:  Karma Yeshi; Roland Ruscher; Luke Hunter; Norelle L Daly; Alex Loukas; Phurpa Wangchuk
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

6.  Pharmacists' Confidence in Managing Patients with Inflammatory Bowel Disease.

Authors:  Sharmila S Prasad; Simon Keely; Nicholas J Talley; Therése Kairuz; Marjorie M Walker
Journal:  Pharmacy (Basel)       Date:  2020-04-17

7.  Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005-2013.

Authors:  Mustafa Shawihdi; Susanna Dodd; Constantinos Kallis; Pete Dixon; Ruth Grainger; Stuart Bloom; Fraser Cummings; Mike Pearson; Keith Bodger
Journal:  Aliment Pharmacol Ther       Date:  2019-05-28       Impact factor: 8.171

8.  Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience.

Authors:  Manuel Barreiro-de Acosta; Ana Gutiérrez; Yamile Zabana; Belén Beltrán; Xavier Calvet; María Chaparro; Eugeni Domènech; Maria Esteve; Julian Panés; Javier P Gisbert; Pilar Nos
Journal:  United European Gastroenterol J       Date:  2021-06-05       Impact factor: 6.866

9.  Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease.

Authors:  Patricia Kaazan; Tracy Li; Warren Seow; Jana Bednarz; Joseph L Pipicella; Krupa Krishnaprasad; Watson Ng; Astrid-Jane Williams; Susan J Connor; Jane M Andrews
Journal:  JGH Open       Date:  2021-08-07

10.  Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes.

Authors:  Antonina Mikocka-Walus; Wayne Massuger; Simon R Knowles; Gregory T Moore; Stephanie Buckton; William Connell; Paul Pavli; Leanne Raven; Jane M Andrews
Journal:  JGH Open       Date:  2019-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.